Pear Therapeutics (Nasdaq:PEAR) shares rose after hours on mixed third-quarter results compared to the consensus forecast.
The company also announced a large set of layoffs, following a previous workforce reduction in July.
Shares of PEAR rose 7.1% at $2.70 apiece after the market closed today. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — finished today up 5.8%.
Get the full story at our sister site, Drug Delivery Business News.